"Designing Growth Strategies is in our DNA"

COVID-19 Diagnostics Market Size, Share & Impact Analysis, By Product (Instruments and Reagents & Kits), By Technology (Polymerase Chain Reaction [PCR], Enzyme-Linked Immunosorbent Assay [ELISA], Lateral Flow Immunoassay [LFIA], and Others), By Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Nasal Swabs, Blood, and Others), By Setting (Lab-Based and Point of Care), By End-user (Hospitals & Clinics, Laboratories & Diagnostic Centers, Home Testing, and Others), and Regional Forecast, 2022-2029

Last Updated: February 24, 2025 | Format: PDF | Report ID: FBI103291

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Overview: Guidelines of COVID-19 Diagnosis
    2. New Product launches
    3. Prevalence of COVID-19 Diseases
    4. Number of Tests for 2020 & 2021
    5. Impact of COVID-19 on Diagnostic Market
    6. Overview of Regulatory Scenario
    7. Impact on Supply Chain of Diagnostics Amid the Pandemic
    8. Key Industry Developments
    9. Recent Launches/Developments Pertaining to Mobile/On-site COVID-19 Testing
  5. Global COVID-19 Diagnostics Market Analysis, Insights & Forecast, 2020-2029 - Scenario 1
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    3. Market Analysis, Insights and Forecast – By Technology
      1. Polymerase Chain Reaction (PCR)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Lateral Flow Immunoassay (LFIA)
      4. Others
    4. Market Analysis, Insights and Forecast – By Sample Type
      1. Oropharyngeal & Nasopharyngeal Swabs
      2. Nasal Swabs
      3. Blood
      4. Others
    5. Market Analysis, Insights and Forecast – By Setting
      1. Lab-based
      2. Point of Care
    6. Market Analysis, Insights and Forecast – By End user
      1. Hospitals & Clinics
      2. Laboratories & Diagnostic Centers
      3. Home Testing
      4. Others
    7. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2029 – Scenario 1
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    3. Market Analysis, Insights and Forecast – By Technology
      1. Polymerase Chain Reaction (PCR)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Lateral Flow Immunoassay (LFIA)
      4. Others
    4. Market Analysis, Insights and Forecast – By Sample Type
      1. Oropharyngeal & Nasopharyngeal Swabs
      2. Nasal Swabs
      3. Blood
      4. Others
    5. Market Analysis, Insights and Forecast – By Setting
      1. Lab-based
      2. Point of Care
    6. Market Analysis, Insights and Forecast – By End user
      1. Hospitals & Clinics
      2. Laboratories & Diagnostic Centers
      3. Home Testing
      4. Others
    7. Market Analysis, Insights, and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2029 – Scenario 1
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    3. Market Analysis, Insights and Forecast – By Technology
      1. Polymerase Chain Reaction (PCR)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Lateral Flow Immunoassay (LFIA)
      4. Others
    4. Market Analysis, Insights and Forecast – By Sample Type
      1. Oropharyngeal & Nasopharyngeal Swabs
      2. Nasal Swabs
      3. Blood
      4. Others
    5. Market Analysis, Insights and Forecast – By Setting
      1. Lab-based
      2. Point of Care
    6. Market Analysis, Insights and Forecast – By End user
      1. Hospitals & Clinics
      2. Laboratories & Diagnostic Centers
      3. Home Testing
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
  8. Asia Pacific COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2029 – Scenario 1
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    3. Market Analysis, Insights and Forecast – By Technology
      1. Polymerase Chain Reaction (PCR)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Lateral Flow Immunoassay (LFIA)
      4. Others
    4. Market Analysis, Insights and Forecast – By Sample Type
      1. Oropharyngeal & Nasopharyngeal Swabs
      2. Nasal Swabs
      3. Blood
      4. Others
    5. Market Analysis, Insights and Forecast – By Setting
      1. Lab-based
      2. Point of Care
    6. Market Analysis, Insights and Forecast – By End user
      1. Hospitals & Clinics
      2. Laboratories & Diagnostic Centers
      3. Home Testing
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. India
      3. Australia
      4. South Korea
      5. Rest of Asia Pacific
  9. Latin America COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2029 – Scenario 1
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    3. Market Analysis, Insights and Forecast – By Technology
      1. Polymerase Chain Reaction (PCR)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Lateral Flow Immunoassay (LFIA)
      4. Others
    4. Market Analysis, Insights and Forecast – By Sample Type
      1. Oropharyngeal & Nasopharyngeal Swabs
      2. Nasal Swabs
      3. Blood
      4. Others
    5. Market Analysis, Insights and Forecast – By Setting
      1. Lab-based
      2. Point of Care
    6. Market Analysis, Insights and Forecast – By End user
      1. Hospitals & Clinics
      2. Laboratories & Diagnostic Centers
      3. Home Testing
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2029 – Scenario 1
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    3. Market Analysis, Insights and Forecast – By Technology
      1. Polymerase Chain Reaction (PCR)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Lateral Flow Immunoassay (LFIA)
      4. Others
    4. Market Analysis, Insights and Forecast – By Sample Type
      1. Oropharyngeal & Nasopharyngeal Swabs
      2. Nasal Swabs
      3. Blood
      4. Others
    5. Market Analysis, Insights and Forecast – By Setting
      1. Lab-based
      2. Point of Care
    6. Market Analysis, Insights and Forecast – By End user
      1. Hospitals & Clinics
      2. Laboratories & Diagnostic Centers
      3. Home Testing
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. South Africa
      2. GCC
      3. Rest of Middle East & Africa
  11. Global COVID-19 Diagnostics Market Analysis, Insights & Forecast, 2020-2029 - Scenario 2
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    3. Market Analysis, Insights and Forecast – By Technology
      1. Polymerase Chain Reaction (PCR)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Lateral Flow Immunoassay (LFIA)
      4. Others
    4. Market Analysis, Insights and Forecast – By Sample Type
      1. Oropharyngeal & Nasopharyngeal Swabs
      2. Nasal Swabs
      3. Blood
      4. Others
    5. Market Analysis, Insights and Forecast – By Setting
      1. Lab-based
      2. Point of Care
    6. Market Analysis, Insights and Forecast – By End user
      1. Hospitals & Clinics
      2. Laboratories & Diagnostic Centers
      3. Home Testing
      4. Others
    7. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  12. North America COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2029 – Scenario 2
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    3. Market Analysis, Insights and Forecast – By Technology
      1. Polymerase Chain Reaction (PCR)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Lateral Flow Immunoassay (LFIA)
      4. Others
    4. Market Analysis, Insights and Forecast – By Sample Type
      1. Oropharyngeal & Nasopharyngeal Swabs
      2. Nasal Swabs
      3. Blood
      4. Others
    5. Market Analysis, Insights and Forecast – By Setting
      1. Lab-based
      2. Point of Care
    6. Market Analysis, Insights and Forecast – By End user
      1. Hospitals & Clinics
      2. Laboratories & Diagnostic Centers
      3. Home Testing
      4. Others
    7. Market Analysis, Insights, and Forecast – By Country
      1. U.S.
      2. Canada
  13. Europe COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2029 – Scenario 2
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    3. Market Analysis, Insights and Forecast – By Technology
      1. Polymerase Chain Reaction (PCR)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Lateral Flow Immunoassay (LFIA)
      4. Others
    4. Market Analysis, Insights and Forecast – By Sample Type
      1. Oropharyngeal & Nasopharyngeal Swabs
      2. Nasal Swabs
      3. Blood
      4. Others
    5. Market Analysis, Insights and Forecast – By Setting
      1. Lab-based
      2. Point of Care
    6. Market Analysis, Insights and Forecast – By End user
      1. Hospitals & Clinics
      2. Laboratories & Diagnostic Centers
      3. Home Testing
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
  14. Asia Pacific COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2029 – Scenario 2
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    3. Market Analysis, Insights and Forecast – By Technology
      1. Polymerase Chain Reaction (PCR)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Lateral Flow Immunoassay (LFIA)
      4. Others
    4. Market Analysis, Insights and Forecast – By Sample Type
      1. Oropharyngeal & Nasopharyngeal Swabs
      2. Nasal Swabs
      3. Blood
      4. Others
    5. Market Analysis, Insights and Forecast – By Setting
      1. Lab-based
      2. Point of Care
    6. Market Analysis, Insights and Forecast – By End user
      1. Hospitals & Clinics
      2. Laboratories & Diagnostic Centers
      3. Home Testing
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. India
      3. Australia
      4. South Korea
      5. Rest of Asia Pacific
  15. Latin America COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2029 – Scenario 2
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    3. Market Analysis, Insights and Forecast – By Technology
      1. Polymerase Chain Reaction (PCR)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Lateral Flow Immunoassay (LFIA)
      4. Others
    4. Market Analysis, Insights and Forecast – By Sample Type
      1. Oropharyngeal & Nasopharyngeal Swabs
      2. Nasal Swabs
      3. Blood
      4. Others
    5. Market Analysis, Insights and Forecast – By Setting
      1. Lab-based
      2. Point of Care
    6. Market Analysis, Insights and Forecast – By End user
      1. Hospitals & Clinics
      2. Laboratories & Diagnostic Centers
      3. Home Testing
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  16. Middle East & Africa COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2029 – Scenario 2
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    3. Market Analysis, Insights and Forecast – By Technology
      1. Polymerase Chain Reaction (PCR)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Lateral Flow Immunoassay (LFIA)
      4. Others
    4. Market Analysis, Insights and Forecast – By Sample Type
      1. Oropharyngeal & Nasopharyngeal Swabs
      2. Nasal Swabs
      3. Blood
      4. Others
    5. Market Analysis, Insights and Forecast – By Setting
      1. Lab-based
      2. Point of Care
    6. Market Analysis, Insights and Forecast – By End user
      1. Hospitals & Clinics
      2. Laboratories & Diagnostic Centers
      3. Home Testing
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. South Africa
      2. GCC
      3. Rest of Middle East & Africa
  17. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, Financials (based on availability))
      1. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      2. Abbott
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      3. Danaher
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      4. Siemens Healthineers AG
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      5. Quidel Corporation
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      6. bioMérieux SA
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      7. Quest Diagnostics Incorporated
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      8. Thermo Fisher Scientific Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      9. PerkinElmer Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
Read Less

Figure 01: Global COVID-19 Diagnostics Market Value Share (%), By Product, 2021 & 2029

Figure 02: Global COVID-19 Diagnostics Market Value Share (%), By Technology, 2021 & 2029

Figure 03: Global COVID-19 Diagnostics Market Value Share (%), By Sample Type, 2021 & 2029

Figure 04: Global COVID-19 Diagnostics Market Value Share (%), By Setting, 2021 & 2029

Figure 05: Global COVID-19 Diagnostics Market Value Share (%), By End user, 2021 & 2029

Figure 06: Global COVID-19 Diagnostics Market Value Share (%), by Region, 2021 & 2029

Figure 07: North America COVID-19 Diagnostics Market Value Share (%), By Product, 2021 & 2029

Figure 08: North America COVID-19 Diagnostics Market Value Share (%), by Country, 2021 & 2029

Figure 09: North America COVID-19 Diagnostics Market Value Share (%), By Technology, 2021 & 2029

Figure 10: North America COVID-19 Diagnostics Market Value Share (%), By Sample Type, 2021 & 2029

Figure 11: North America COVID-19 Diagnostics Market Value Share (%), By Setting, 2021 & 2029

Figure 12: North America COVID-19 Diagnostics Market Value Share (%), By End user, 2021 & 2029

Figure 13: Europe COVID-19 Diagnostics Market Value Share (%), By Product, 2021 & 2029

Figure 14: Europe COVID-19 Diagnostics Market Value Share (%), by Country/sub-region, 2021 & 2029

Figure 15: Europe COVID-19 Diagnostics Market Value Share (%), By Technology, 2021 & 2029

Figure 16: Europe COVID-19 Diagnostics Market Value Share (%), By Sample Type, 2021 & 2029

Figure 17: Europe COVID-19 Diagnostics Market Value Share (%), By Setting, 2021 & 2029

Figure 18: Europe COVID-19 Diagnostics Market Value Share (%), By End user, 2021 & 2029

Figure 19: Asia Pacific COVID-19 Diagnostics Market Value Share (%), By Product, 2021 & 2029

Figure 20: Asia Pacific COVID-19 Diagnostics Market Value Share (%), by Country/sub-region, 2021 & 2029

Figure 21: Asia Pacific COVID-19 Diagnostics Market Value Share (%), By Technology, 2021 & 2029

Figure 22: Asia Pacific COVID-19 Diagnostics Market Value Share (%), By Sample Type, 2021 & 2029

Figure 23: Asia Pacific COVID-19 Diagnostics Market Value Share (%), By Setting, 2021 & 2029

Figure 24: Asia Pacific COVID-19 Diagnostics Market Value Share (%), By End user, 2021 & 2029

Figure 25: Latin America COVID-19 Diagnostics Market Value Share (%), By Product, 2021 & 2029

Figure 26: Latin America COVID-19 Diagnostics Market Value Share (%), by Country/sub-region, 2021 & 2029

Figure 27: Latin America COVID-19 Diagnostics Market Value Share (%), By Technology, 2021 & 2029

Figure 28: Latin America COVID-19 Diagnostics Market Value Share (%), By Sample Type, 2021 & 2029

Figure 29: Latin America COVID-19 Diagnostics Market Value Share (%), By Setting, 2021 & 2029

Figure 30: Latin America COVID-19 Diagnostics Market Value Share (%), By End user, 2021 & 2029

Figure 31: Middle East & Africa COVID-19 Diagnostics Market Value Share (%), By Product, 2021 & 2029

Figure 32: Middle East & Africa COVID-19 Diagnostics Market Value Share (%), by Country/sub-region, 2021 & 2029

Figure 33: Middle East & Africa COVID-19 Diagnostics Market Value Share (%), By Technology, 2021 & 2029

Figure 34: Middle East & Africa COVID-19 Diagnostics Market Value Share (%), By Sample Type, 2021 & 2029

Figure 35: Middle East & Africa COVID-19 Diagnostics Market Value Share (%), By Setting, 2021 & 2029

Figure 36: Middle East & Africa COVID-19 Diagnostics Market Value Share (%), By End user, 2021 & 2029

Figure 37: Global COVID-19 Diagnostics Market Value Share (%), By Product, 2021 & 2029

Figure 38: Global COVID-19 Diagnostics Market Value Share (%), By Technology, 2021 & 2029

Figure 39: Global COVID-19 Diagnostics Market Value Share (%), By Sample Type, 2021 & 2029

Figure 40: Global COVID-19 Diagnostics Market Value Share (%), By Setting, 2021 & 2029

Figure 41: Global COVID-19 Diagnostics Market Value Share (%), By End user, 2021 & 2029

Figure 42: Global COVID-19 Diagnostics Market Value Share (%), by Region, 2021 & 2029

Figure 43: North America COVID-19 Diagnostics Market Value Share (%), By Product, 2021 & 2029

Figure 44: North America COVID-19 Diagnostics Market Value Share (%), by Country, 2021 & 2029

Figure 45: North America COVID-19 Diagnostics Market Value Share (%), By Technology, 2021 & 2029

Figure 46: North America COVID-19 Diagnostics Market Value Share (%), By Sample Type, 2021 & 2029

Figure 47: North America COVID-19 Diagnostics Market Value Share (%), By Setting, 2021 & 2029

Figure 48: North America COVID-19 Diagnostics Market Value Share (%), By End user, 2021 & 2029

Figure 49: Europe COVID-19 Diagnostics Market Value Share (%), By Product, 2021 & 2029

Figure 50: Europe COVID-19 Diagnostics Market Value Share (%), by Country/sub-region, 2021 & 2029

Figure 51: Europe COVID-19 Diagnostics Market Value Share (%), By Technology, 2021 & 2029

Figure 52: Europe COVID-19 Diagnostics Market Value Share (%), By Sample Type, 2021 & 2029

Figure 53: Europe COVID-19 Diagnostics Market Value Share (%), By Setting, 2021 & 2029

Figure 54: Europe COVID-19 Diagnostics Market Value Share (%), By End user, 2021 & 2029

Figure 55: Asia Pacific COVID-19 Diagnostics Market Value Share (%), By Product, 2021 & 2029

Figure 56: Asia Pacific COVID-19 Diagnostics Market Value Share (%), by Country/sub-region, 2021 & 2029

Figure 57: Asia Pacific COVID-19 Diagnostics Market Value Share (%), By Technology, 2021 & 2029

Figure 58: Asia Pacific COVID-19 Diagnostics Market Value Share (%), By Sample Type, 2021 & 2029

Figure 59: Asia Pacific COVID-19 Diagnostics Market Value Share (%), By Setting, 2021 & 2029

Figure 60: Asia Pacific COVID-19 Diagnostics Market Value Share (%), By End user, 2021 & 2029

Figure 61: Latin America COVID-19 Diagnostics Market Value Share (%), By Product, 2021 & 2029

Figure 62: Latin America COVID-19 Diagnostics Market Value Share (%), by Country/sub-region, 2021 & 2029

Figure 63: Latin America COVID-19 Diagnostics Market Value Share (%), By Technology, 2021 & 2029

Figure 64: Latin America COVID-19 Diagnostics Market Value Share (%), By Sample Type, 2021 & 2029

Figure 65: Latin America COVID-19 Diagnostics Market Value Share (%), By Setting, 2021 & 2029

Figure 66: Latin America COVID-19 Diagnostics Market Value Share (%), By End user, 2021 & 2029

Figure 67: Middle East & Africa COVID-19 Diagnostics Market Value Share (%), By Product, 2021 & 2029

Figure 68: Middle East & Africa COVID-19 Diagnostics Market Value Share (%), by Country/sub-region, 2021 & 2029

Figure 69: Middle East & Africa COVID-19 Diagnostics Market Value Share (%), By Technology, 2021 & 2029

Figure 70: Middle East & Africa COVID-19 Diagnostics Market Value Share (%), By Sample Type, 2021 & 2029

Figure 71: Middle East & Africa COVID-19 Diagnostics Market Value Share (%), By Setting, 2021 & 2029

Figure 72: Middle East & Africa COVID-19 Diagnostics Market Value Share (%), By End user, 2021 & 2029

Figure 73: Global COVID-19 Diagnostics Market Share Analysis (%), By Company, 2021

Table 01: Global COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Product, 2020–2029

Table 02: Global COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Technology, 2020–2029

Table 03: Global COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Sample Type, 2020–2029

Table 04: Global COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Setting, 2020–2029

Table 05: Global COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By End user, 2020–2029

Table 06: Global COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Region, 2020–2029

Table 07: North America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Product, 2020–2029

Table 08: North America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Technology, 2020–2029

Table 09: North America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Sample Type, 2020–2029

Table 10: North America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Setting, 2020–2029

Table 11: North America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By End user, 2020–2029

Table 12: North America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, by Country, 2020–2029

Table 13: Europe COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Product, 2020–2029

Table 14: Europe COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Technology, 2020–2029

Table 15: Europe COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Sample Type, 2020–2029

Table 16: Europe COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Setting, 2020–2029

Table 17: Europe COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By End user, 2020–2029

Table 18: Europe COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Country/sub-region, 2020–2029

Table 19: Asia Pacific COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Product, 2020–2029

Table 20: Asia Pacific COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Technology, 2020–2029

Table 21: Asia Pacific COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Sample Type, 2020–2029

Table 22: Asia Pacific COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Setting, 2020–2029

Table 23: Asia Pacific COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By End user, 2020–2029

Table 24: Asia Pacific COVID-19 Diagnostics Market Revenue (USD billion) Forecast, by Country/sub-region, 2020–2029

Table 25: Latin America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Product, 2020–2029

Table 26: Latin America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Technology, 2020–2029

Table 27: Latin America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Sample Type, 2020–2029

Table 28: Latin America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Setting, 2020–2029

Table 29: Latin America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By End user, 2020–2029

Table 30: Latin America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, by Country/sub-region, 2020–2029

Table 31: Middle East & Africa COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Product, 2020–2029

Table 32: Middle East & Africa COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Technology, 2020–2029

Table 33: Middle East & Africa COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Sample Type, 2020–2029

Table 34: Middle East & Africa COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Setting, 2020–2029

Table 35: Middle East & Africa COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By End user, 2020–2029

Table 36: Middle East & Africa COVID-19 Diagnostics Market Revenue (USD billion) Forecast, by Country/sub-region, 2020–2029

Table 37: Global COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Product, 2020–2029

Table 38: Global COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Technology, 2020–2029

Table 39: Global COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Sample Type, 2020–2029

Table 40: Global COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Setting, 2020–2029

Table 41: Global COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By End user, 2020–2029

Table 42: Global COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Region, 2020–2029

Table 43: North America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Product, 2020–2029

Table 44: North America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Technology, 2020–2029

Table 45: North America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Sample Type, 2020–2029

Table 46: North America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Setting, 2020–2029

Table 47: North America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By End user, 2020–2029

Table 48: North America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, by Country, 2020–2029

Table 49: Europe COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Product, 2020–2029

Table 50: Europe COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Technology, 2020–2029

Table 51: Europe COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Sample Type, 2020–2029

Table 52: Europe COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Setting, 2020–2029

Table 53: Europe COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By End user, 2020–2029

Table 54: Europe COVID-19 Diagnostics Market Revenue (USD billion) Forecast, by Country/sub-region, 2020–2029

Table 55: Asia Pacific COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Product, 2020–2029

Table 56: Asia Pacific COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Technology, 2020–2029

Table 57: Asia Pacific COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Sample Type, 2020–2029

Table 58: Asia Pacific COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Setting, 2020–2029

Table 59: Asia Pacific COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By End user, 2020–2029

Table 60: Asia Pacific COVID-19 Diagnostics Market Revenue (USD billion) Forecast, by Country/sub-region, 2020–2029

Table 61: Latin America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Product, 2020–2029

Table 62: Latin America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Technology, 2020–2029

Table 63: Latin America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Sample Type, 2020–2029

Table 64: Latin America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Setting, 2020–2029

Table 65: Latin America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By End user, 2020–2029

Table 66: Latin America COVID-19 Diagnostics Market Revenue (USD billion) Forecast, by Country/sub-region, 2020–2029

Table 67: Middle East & Africa COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Product, 2020–2029

Table 68: Middle East & Africa COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Technology, 2020–2029

Table 69: Middle East & Africa COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Sample Type, 2020–2029

Table 70: Middle East & Africa COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By Setting, 2020–2029

Table 71: Middle East & Africa COVID-19 Diagnostics Market Revenue (USD billion) Forecast, By End user, 2020–2029

Table 72: Middle East & Africa COVID-19 Diagnostics Market Revenue (USD billion) Forecast, by Country/sub-region, 2020–2029

COVID-19 Diagnostics Market Size, Share and Global Industry Trend Forecast till 2029
  • 2020-2029
  • 2021
  • 2020 - 2027
  • 194
Consulting Services
    How will you benefit from our consulting services ?